ED
45
2
MTB
49
5
O
26
6
CMA
59
7
AFL
42
5
L
49
4
NWL
52
4
JBHT
56
3
ORCL
38
2
INTU
50
5
PFE
37
-5
GT
37
4
PH
59
2
WEC
46
3
VRSN
59
2
EXC
64
3
BAC
54
4
SHW
45
2
HPE
55
4
MAS
52
9
ED
45
2
MTB
49
5
O
26
6
CMA
59
7
AFL
42
5
L
49
4
NWL
52
4
JBHT
56
3
ORCL
38
2
INTU
50
5
PFE
37
-5
GT
37
4
PH
59
2
WEC
46
3
VRSN
59
2
EXC
64
3
BAC
54
4
SHW
45
2
HPE
55
4
MAS
52
9
Financhill
Back

Aligos Therapeutics Stock Predictions

Try a Free Stock Analysis With Definitive Buy Sell Hold Ratings

Analyze Any Stock Free
Sell
29

ALGS
Aligos Therapeutics

Last Price:
$30.08
Seasonality Move:
-18.25%

7 Day Trial

ALL ACCESS PASS

$ 7

Free Stock Analysis Report: See The True Value of Any Stock

Analyze Any Stock Free

Aligos Therapeutics Stock Forecast

  • Over the next 52 weeks, Aligos Therapeutics has on average historically fallen by 22.5% based on the past 4 years of stock performance.
  • Aligos Therapeutics has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
  • Is Aligos Therapeutics Stock Undervalued?
    The current Aligos Therapeutics [ALGS] share price is $30.05. The Score for ALGS is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • ALGS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Aligos Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Aligos Therapeutics has on average historically fallen by 22.5% based on the past 4 years of stock performance.

Aligos Therapeutics Stock Rating

Sell
29
Aligos Therapeutics (ALGS) is a Sell

Is Aligos Therapeutics overpriced?

  • Aligos Therapeutics has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

Aligos Therapeutics Stock Price History

Is ALGS stock going to rise?

  • The current trend is moderately bearish and ALGS is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
aligos.com

52-Week Data

52-Week High:
46.80
52-Week Low:
6.76

Prediction Charts

Market Cap:
107.8M
Price in USD:
30.05
Volume:
345K
Beta:
2.52

Technical Analysis

SMA50:
27.37
SMA100:
18.85
SMA200:
17.35
52-Wk Change:
63.07%

Stock Predictions

  • Is Aligos Therapeutics stock public?
    Yes, Aligos Therapeutics is a publicly traded company.
  • What is the Aligos Therapeutics stock quote today?
    The Aligos Therapeutics stock price is 30.05 USD today.
  • How to buy Aligos Therapeutics stock online?
    You can buy Aligos Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-23 42.10 38.85 42.95 38.61
Dec-24 40.98 39.34 42.42 38.90
Dec-26 40.00 43.37 43.94 38.13
Dec-27 43.00 41.15 44.39 39.54
Dec-30 39.88 40.47 41.14 37.06
Dec-31 41.15 39.84 41.30 34.53
Jan-2 40.45 39.82 42.25 38.00
Jan-3 40.35 43.42 44.30 40.30
Jan-6 44.50 45.62 46.80 42.50
Jan-7 46.25 40.92 46.32 40.56
Jan-8 40.13 38.39 40.81 36.36
Jan-10 36.09 33.71 37.12 28.10
Jan-13 32.08 34.34 35.00 31.00
Jan-14 35.04 30.05 35.30 29.35

Aligos Therapeutics Earnings

Aligos Therapeutics Earnings Report: Per Share Aligos Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Aligos Therapeutics Forecast Revenue Growth

Aligos Therapeutics Stock Analysis: Historical quarterly revenues per share for Aligos Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.65 per share, and a decrease next year of $0.14 per share.

* Aligos Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.